ABSENCE OF POINT MUTATIONS IN A FUNCTIONALLY IMPORTANT PART OF THE EXTRACELLULAR DOMAIN OF THE C-KIT PROTOONCOGENE IN A SERIES OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)

被引:0
|
作者
ARLAND, M [1 ]
FIEDLER, W [1 ]
SAMALECOS, A [1 ]
HOSSFELD, DK [1 ]
机构
[1] UNIV HAMBURG,HOSP EPPENDORF,DEPT HEMATOL ONCOL,D-20246 HAMBURG,GERMANY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proto-oncogenes c-fms and c-kit belong to a family of growth factor receptors possessing protein kinase activity. It has been shown that transfection of a c-fms gene carrying a point mutation at codon 301, leads to a ligand-independent transformation of mouse NIH3T3 cells. In human acute myeloid leukemia (AML), point mutations at codon 301 of the c-fms gene have been observed implying an important role in the transformation process. The possibility of a point mutation of the c-kit proto-oncogene was investigated. We sequenced a segment of the c-kit proto-oncogene coding for a part of the extracellular domain. This segment was 40.7% homologous to the c-fms region encompassing codon 301. c-DNA was prepared from peripheral blood or bone marrow cells from 25 patients with AML, from four patients with myelodysplastic syndrome (MDS) and from three human myeloid cell lines. The region of interest was amplified with two rounds of polymerase chain reactions (PCR) with nested primers and directly sequenced. No point mutations were found in the investigated samples. Thus, point mutations in this segment of the c-kit gene do not seem to play an important role in the transformation process of human acute leukemia.
引用
收藏
页码:498 / 501
页数:4
相关论文
共 50 条
  • [41] Molecular and Clinical Features of FLT3 Juxtamembrane Domain Point Mutations (muts) in Acute Myeloid Leukemia (AML)
    Anabtawi, Nadeen
    Kohlschmidt, Jessica
    Buelow, Daelynn
    Orwick, Shelley
    Coleman, Kennedy
    Mrozek, Krzysztof
    Kolitz, Jonathan E.
    Powell, Bayard L.
    Blum, William G.
    Baer, Maria R.
    Byrd, John C.
    Stock, Wendy
    Uy, Geoffrey L.
    Eisfeld, Ann-Kathrin
    Baker, Sharyn
    Blachly, James S.
    BLOOD, 2022, 140 : 6244 - 6246
  • [42] TNF-ALPHA DOWN-REGULATES THE EXPRESSION OF C-KIT ON NORMAL AND ACUTE MYELOID-LEUKEMIA CD34+ CELLS
    KHOURY, E
    PONTVERTDELUCQ, S
    DRENOU, B
    BAILLOU, C
    GUIGON, M
    NAIMAN, A
    LEMOINE, FM
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1076 - 1076
  • [43] Activated leukemic oncogenes AML1-ETO and c-kit: Role in development of acute myeloid leukemia and current approaches for their inhibition
    Rulina, A. V.
    Spirin, P. V.
    Prassolov, V. S.
    BIOCHEMISTRY-MOSCOW, 2010, 75 (13) : 1650 - 1666
  • [44] Activated leukemic oncogenes AML1-ETO and c-kit: Role in development of acute myeloid leukemia and current approaches for their inhibition
    A. V. Rulina
    P. V. Spirin
    V. S. Prassolov
    Biochemistry (Moscow), 2010, 75 : 1650 - 1666
  • [45] HIGH RESOLUTION MELTING ANALYSIS FOR THE RAPID DETECTION OF C-KIT MUTATIONS IN CORE BINDING FACTOR-ACUTE MYELOID LEUKEMIA
    Fuster, O.
    Barragan, E.
    Bolufer, P.
    Cervera, J.
    Larrayoz, M. J.
    Jimenez, A.
    Martinez, J.
    Valencia, A.
    Moscardo, F.
    Sanz, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 14 - 15
  • [46] ANALYSIS OF C-KIT GENE MUTATIONS IN ACUTE MYELOID LEUKEMIA CHILDREN WITH T(8;21) OR INV(16) IN SINGLE CENTER
    Lin, W.
    Zhou, X.
    Li, W.
    Wu, M.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 75 - 75
  • [47] NPM1, FLT3-ITD, CEBPA, and c-kit mutations in 312 Chinese patients with de novo acute myeloid leukemia
    Su, Long
    Gao, Su Jun
    Li, Wei
    Tan, Ye Hui
    Cui, Jiu Wei
    Hu, Rui Ping
    HEMATOLOGY, 2014, 19 (06) : 324 - 328
  • [48] ENZYMATIC DETERMINANTS OF RESPONSE TO CYTOSINE-ARABINOSIDE (ARA-C) IN PATIENTS (PTS) WITH ACUTE MYELOID-LEUKEMIA (AML)
    RIVA, CM
    DESOUZA, G
    FERRIER, F
    MERLIN, M
    TUBIANA, N
    LEJEUNE, C
    GASTAUT, JA
    BARRA, Y
    CANO, JP
    CARCASSONNE, Y
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 502 - 502
  • [49] AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2
    Jiao, B.
    Wu, C-F
    Liang, Y.
    Chen, H-M
    Xiong, S-M
    Chen, B.
    Shi, J-Y
    Wang, Y-Y
    Wang, J-H
    Chen, Y.
    Li, J-M
    Gu, L-J
    Tang, J-Y
    Shen, Z-X
    Gu, B-W
    Zhao, W-L
    Chen, Z.
    Chen, S-J
    LEUKEMIA, 2009, 23 (09) : 1598 - 1604
  • [50] AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2
    B Jiao
    C-F Wu
    Y Liang
    H-M Chen
    S-M Xiong
    B Chen
    J-Y Shi
    Y-Y Wang
    J-H Wang
    Y Chen
    J-M Li
    L-J Gu
    J-Y Tang
    Z-X Shen
    B-W Gu
    W-L Zhao
    Z Chen
    S-J Chen
    Leukemia, 2009, 23 : 1598 - 1604